Fed Circuit affirms generic maker’s win over Eagle

The US Court of Appeals for the Federal Circuit has affirmed a generic maker’s victory over pharmaceutical company Eagle Pharmaceuticals in a case involving cancer drug Belrapzo (bendamustine hydrochloride injection).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Big Pharma

Fed Circuit limits venue options for generic patent suits

6 November 2020 The US Court of Appeals for the Federal Circuit has narrowed the landscape in which patent infringement suits over generic drugs suits can be filed, in a ruling handed down yesterday, November 5.

Americas

FDA warns of ‘grave’ knock-on effects from Eagle decision

29 May 2020 The US Food and Drug Administration has warned a US Court of Appeals for the DC Circuit decision awarding market exclusivity to Eagle Pharmaceuticals for a cancer drug will have “grave” consequences for patient access.

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Big Pharma

Fed Circuit limits venue options for generic patent suits

Americas

FDA warns of ‘grave’ knock-on effects from Eagle decision

More on this story

Americas

Teva and Eagle try to block Bendeka generic

1 July 2021 Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Big Pharma

Fed Circuit limits venue options for generic patent suits

Americas

FDA warns of ‘grave’ knock-on effects from Eagle decision